Inflammation: Clinical Trials

17 trials for Inflammation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 withdrawn. 17 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 417Withdrawn 17

Follow Inflammation: new trials by email Literature Review of Inflammation trials Research Report on Inflammation

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
Piperacillin / Tazobactam Injection, Meropenem - Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections
Phase 4WithdrawnRambam Health Care Campus2022-07-012025-07-24
Angiotensin II vs. Vasopressin in Septic Shock
Angiotensin II, Vasopressin - Septic Shock
Phase 4WithdrawnUniversity of New Mexico2022-01-032024-03-15
Empagliflozin in Adolescent Diabetes
Empagliflozin - type1diabetes
Phase 4WithdrawnOhio State University2021-07-012023-03-23
Inflammation and Co-Infections in D²EFT
NRTIs, Darunavir, Ritonavir - HIV-infection/Aids, Human Herpesvirus 4 Infections
Phase 4WithdrawnKirby Institute2021-02-012020-11-10
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
Methylprednisolone, Tocilizumab - COVID-19 Virus Infection, Cytokine Storm
Phase 4WithdrawnMarmara University2021-02-012021-11-24
A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk
Elbasvir/grazoprevir - Hepatitis C
Phase 4WithdrawnUniversity of California, Los Angeles2018-08-012018-08-07
Therapeutic Drug Monitoring and Continuous Infusion of Beta-lactam Antibiotics in Patients With Bacteraemia
Continuous infusion of beta-lactam antibiotics ., Therapeutic drug monitoring of beta-lactam antibiotics. - Bacteremia
Phase 4WithdrawnSara Thønnings2017-10-012023-03-29
Midodrine During Recovery From Septic Shock
Midodrine, placebo - Hypotension, Shock, Septic
Phase 4WithdrawnNorthwell Health2017-08-012017-11-06
Antibiotics and Tissue Expanders in Breast Reconstruction
antibiotic - Complications; Breast Prosthesis, Infection or Inflammation
Phase 4WithdrawnEmory University2016-06-012017-02-24
Effectiveness of Nitrous Oxide in the ED
Nitrous Oxide, Oxygen - Lacerations, Abscess
Phase 4WithdrawnChristiana Care Health Services2016-03-012016-07-11
Effects of Intraarticular IL1-Ra on Pain and Inflammatory Mediators After Knee Arhroscopy
Anakinra 100 mg in 2 ml saline IA - Knee Injuries
Phase 4WithdrawnOslo University Hospital2016-03-012021-06-11
The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
Clopidogrel, Ticagrelor - Atherosclerosis
Phase 4WithdrawnBaylor College of Medicine2015-12-012019-12-11
NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock
Vasopressin, Norepinephrine - Shock, Septic
Phase 4WithdrawnUniversity of Arkansas2015-11-012017-11-29
Volume Therapy With Crystalloids and Colloids and Hemodynamic Monitoring in Patients With Severe Sepsis
Volulyte, Jonosteril - Severe Sepsis
Phase 4WithdrawnWuerzburg University Hospital2013-03-012016-11-30
Pain Management in ED for Incision and Drainage of Abscess
Fentanyl, Normal Saline - Abscess
Phase 4WithdrawnUniversity of California, Los Angeles2011-06-012013-06-20
Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Hydrocortisone, Fludrocortisone - Sepsis, Adrenal Insufficiency
Phase 4WithdrawnCAMC Health System2006-09-012026-08-31
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients
Fluconazole, Micafungin - Candidiasis, Sepsis
Phase 4WithdrawnKyoto University2006-08-012024-06-14

Narrower conditions

Sepsis (4)  ·  Shock, Septic (3)  ·  Abscess (2)  ·  Bacteremia (2)  ·  Diabetes Insipidus (2)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Adrenal Insufficiency (1)  ·  Atherosclerosis (1)  ·  COVID-19 (1)  ·  Candidiasis (1)  ·  Coinfection (1)  ·  Cytokine Release Syndrome (1)  ·  Cytomegalovirus Infections (1)  ·  Diabetes Mellitus, Type 1 (1)

Broader conditions

Pathologic Processes (17)  ·  Pathological Conditions, Signs and Symptoms (17)  ·  Infections (13)  ·  Systemic Inflammatory Response Syndrome (8)  ·  Shock (5)  ·  Endocrine System Diseases (4)  ·  Sepsis (4)  ·  Bacterial Infections and Mycoses (3)  ·  RNA Virus Infections (3)  ·  Urogenital Diseases (3)  ·  Virus Diseases (3)  ·  Bacterial Infections (2)  ·  Blood-Borne Infections (2)  ·  Cardiovascular Diseases (2)

Interventions

Meropenem (2)  ·  Piperacillin, Tazobactam Drug Combination (2)  ·  Vasopressins (2)  ·  Adrenal Cortex Hormones (1)  ·  Ampicillin (1)  ·  Angiotensin II (1)  ·  Anti-Bacterial Agents (1)  ·  Arginine Vasopressin (1)  ·  Cefuroxime (1)  ·  Cephalexin (1)  ·  Clindamycin (1)  ·  Clopidogrel (1)  ·  Darunavir (1)  ·  Dicloxacillin (1)  ·  Fentanyl (1)

Sponsors

University of California, Los Angeles (2)  ·  Baylor College of Medicine (1)  ·  CAMC Health System (1)  ·  Christiana Care Health Services (1)  ·  Emory University (1)  ·  Kirby Institute (1)  ·  Kyoto University (1)  ·  Marmara University (1)  ·  Northwell Health (1)  ·  Ohio State University (1)  ·  Oslo University Hospital (1)  ·  Rambam Health Care Campus (1)  ·  Sara Thønnings (1)  ·  University of Arkansas (1)  ·  University of New Mexico (1)

Countries

United States (5)  ·  Israel (1)  ·  Japan (1)  ·  Norway (1)

Top investigators

Adaira Landry, B.A. (1)  ·  Alaa Atamna, MD (1)  ·  Brian Levine, MD (1)  ·  Dafna Yahav, MD (1)  ·  Drayton Hammond, Pharm.D. (1)  ·  Grant W Carlson, MD (1)  ·  Joao P Teixeira, MD (1)  ·  John A Bethea, Pharm.D. (1)  ·  Joshua W Elder, B.S. (1)  ·  Kara W Chew, M.D., M.S. (1)  ·  Larry J Baraff, MD (1)  ·  Mark Polizzotto, MD, PhD (1)  ·  Mical Paul, MD (1)  ·  Nathan D Nielsen, MD MSc (1)  ·  Noa Eliakim-Raz, MD (1)

Results publications

PMID 10321661, PMID 10697064, PMID 10923728, PMID 11555797, PMID 12186604, PMID 12487041, PMID 18090011, PMID 18826731, PMID 19388915, PMID 21063553, PMID 21197290, PMID 2803357, PMID 29600824, PMID 3029157, PMID 3306374, PMID 4101232, PMID 6270176, PMID 6384785, PMID 7600840, PMID 7634816, PMID 7638758, PMID 7862469, PMID 8815944, PMID 8855809, PMID 9491040, PMID 9559600

NIH funding

UL1TR001449 (1)